Dipeptidyl Peptidase-4 Inhibitor (Vildagliptin) Improves Glycemic Control After Meal Tolerance Test by Suppressing Glucagon Release

AIM: We aimed to evaluate changes in insulin and glucagon secretion, as well as glucose levels, with a meal tolerance test (MTT) before and after 6 months of treatment with vildagliptin in a clinical setting. MATERIALS AND METHODS: Participants were 15 patients with uncontrolled type 2 diabetes mell...

Descripción completa

Detalles Bibliográficos
Autores principales: Okamoto, Aki, Yokokawa, Hirohide, Sanada, Hironobu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4269812/
https://www.ncbi.nlm.nih.gov/pubmed/25204760
http://dx.doi.org/10.1007/s40268-014-0062-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4269812/
https://www.ncbi.nlm.nih.gov/pubmed/25204760
http://dx.doi.org/10.1007/s40268-014-0062-8

Ejemplares similares